Home | Welcome to Contract Pharma   
Last Updated Sunday, March 29 2015

Print

Search Results for 'Financial Reports: Biogen Idec'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published January 30, 2015
MS portfolio drives growth Read More »
Published October 22, 2014
Revenues up 37% as TECFIDERA sales soar Read More »
Published April 23, 2014
51% growth driven by MS franchise Read More »
By Kristin Brooks
Published January 29, 2014
Expanded MS franchise drives growth Read More »
Published July 25, 2013
Revenues up 21% in the quarter with Tecfidera launch Read More »
By Gil Roth
Published January 28, 2013
MS franchise continues growth trend Read More »
Published October 25, 2012
Revenues up 6% in the quarter on Avonex boost Read More »
Published July 24, 2012
Revenues up 18% in the quarter Read More »
By Gil Roth
Published May 1, 2012
Revenues up, but R&D costs put a crimp in earnings Read More »
Published January 31, 2012
In-market Tysabri sales up 23% in 2011 Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On